MARY'S STORY REFLUX TESTING AND TREATMENT

RADIOFREQUENCY ABLATION

Patients with Barrett’s esophagus are routinely monitored to watch for progression to high-grade dysplasia, which is the critical step towards the development of cancer. Until recently, the only reliable treatment at this point was an esophagectomy, or surgical removal of part or all of the esophagus.

Now, however, a new and minimally invasive technology known as radiofrequency ablation (RFA) is becoming available in Canadian hospitals, giving patients such as Mary a far more positive prognosis.

“When I was diagnosed with Barrett’s esophagus,” she recalls, “my family doctor would bring me in every three to six months to check it, and then when it became high-dysplasia, he referred me to Dr. Dhaliwal.”

Dr. Harry Dhaliwal is a therapeutic gastroenterologist at The Ottawa Hospital, which recently acquired an RFA system called Barrx^TM.

“When I did the initial diagnostic endoscopy to evaluate the Barrett’s mucosa, Mary had two nodules within that area,” he says. “When those nodules were removed, they both contained cancer. With RFA and ablative therapy, we’re able to treat patients early. This prevents the progression to high-grade dysplasia, which was previously treated with esophagectomy.”

RFA technology uses current to create heat that eradicates tissues affected by Barrett’s esophagus. With the patient under sedation, the physician inserts a catheter into the esophagus. The catheter carries an inflatable balloon containing bands that emit radio waves with great precision. When the balloon is inflated, the physician delivers a burst of energy that ablates, or destroys, the abnormal cells. The body will later replace these cells with healthy ones.

“RFA is a proven technology for treating Barrett’s mucosa,” says Dr. Dhaliwal. “It’s very tolerable and there’s a very durable response.” Indeed, RFA technology has been shown to be 98.4% effective at eliminating dysplastic Barrett’s esophagus tissue.³

The outcome for Mary could not have been better. A follow-up endoscopy showed that the RFA procedure was a complete success. Since then she feels great, has got married and is starting a new life.

“I really feel that a patient should be their own best friend,” she says now. “Anybody who has a history like I had should get checked.”

However, Dr. Dhaliwal warns, “One of the difficulties in identifying patients with Barrett’s esophagus is that there’s a large percentage who don’t actually experience symptoms of acid reflux. They may have undiagnosed Barrett’s esophagus that we may not be aware of. We often miss those patients, so part of the struggle for us as physicians is being able to screen patients properly and selectively.”

At present there’s no consistent screening protocol for high-risk patients similar to the program for colon cancer, and healthcare resources for endoscopies are limited.

“Patients who do have risk factors and symptoms of reflux for an extended period of time should be getting surveyed,” Dr. Dhaliwal says. “Even younger patients who have a longstanding history of reflux and have Barrett’s mucosa, if there’s a family history of esophageal cancer or there’s a large segment of Barrett’s, should be considered for ablative therapy.”

“It’s important to be your own advocate,” Mary adds. “Anyone who has acid reflux should be aware that it could lead to Barrett’s esophagus. If you’ve had GERD for a long time, talk to your doctor. I was just lucky.”